Ingen's Patented Smart Nasal Cannula and Oxyview Increased Market Growth
November 25 2013 - 7:30AM
Marketwired
Ingen's Patented Smart Nasal Cannula and Oxyview Increased Market
Growth
The Worldwide Market for Respiratory Devices Had an Estimated
Worth of $4.5 Billion in 2010, According to Global Data, With
Forecasts Predicting a $2.6 Billion Increase in Revenue by 2017 for
a 7% Yearly Growth Rate
RIVERSIDE, CA--(Marketwired - Nov 25, 2013) - Ingen Technologies
Inc. (PINKSHEETS: IGNT), (http://ingen-tech.com) the holding
company of two subsidiaries; a medical device manufacturing company
selling its patented medical products worldwide, and a newly
acquired growing telecom business providing services to major
telecom companies worldwide, announces today that demand for
respiratory devices is fuelled by rising cases of respiratory
illnesses, primarily asthma and chronic obstructive pulmonary
disease; i.e. chronic bronchitis and emphysema.
"Although our newly acquired Telecom business is on track for
future growth, today, we want to speak about the turnaround in our
medical division," stated Gary B. Tilden, Chairman. "Our Oxyview
product is finally starting to gain appeal in the respiratory
device market which includes ventilators, inhalers, oxygen
concentrators, aerosol therapy nebulizers and positive airway
pressure devices. We are fortunate that our product reaches these
medical, government and commercial markets, such as TopOut where
distribution of Oxyview with their high-altitude mountain climbing
oxygen systems is a priority. Product diversity is one big
advantage to our growing revenue stream since it enhances savings
with n-home care services, under the changing healthcare market. We
are extremely optimistic about the future of both businesses going
forward."
Safe Harbor for Forward-Looking Statements: This news release
includes forward-looking statements. While these statements are
made to convey to the public the company's progress, business
opportunities and growth prospects, readers are cautioned that such
forward-looking statements represent management's opinion. Whereas
management believes such representations to be true and accurate
based on information and data available to the company at this
time, actual results may differ materially from those described.
The company's operations and business prospects are always subject
to risk and uncertainties. Important factors that may cause actual
results to differ are and will be set forth in the company's
periodic filings with the U.S. Securities and Exchange
Commission.
CONTACT: Gary Tilden 951-688-7840 www.ingen-tech.com Email
Contact www.useatmc.com
Ingen Technologies (CE) (USOTC:IGNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ingen Technologies (CE) (USOTC:IGNT)
Historical Stock Chart
From Sep 2023 to Sep 2024